Preliminary evidence for bioactivity of IL-1 trap (rilonacept), a long acting IL-1 inhibitor, in systemic juvenile idiopathic arthritis

被引：0
|
作者：
Lovell, D.
Giannini, E.
Kimura, Y.
Lil, S.
Hashkes, R.
Reiff, A.
Wallace, C.
Onei, K.
Nadler, D.
Rosenberg, J.
Osgood, G.
Papadopoulos, J.
Radin, A.
机构：
[1] Childrens Hosp, Med Ctr, Cincinnati, OH 45229 USA
[2] Hackensack Univ, Med Ctr, Hackensack, NJ USA
[3] Cleveland Clin Fdn, Cleveland, Qld, Australia
[4] Childrens Hosp Los Angeles, Los Angeles, CA 90027 USA
[5] Childrens Hosp, Reg Med Ctr, Seattle, WA USA
[6] Univ Chicago, La Rabida Childrens Hosp, Chicago, IL 60637 USA
[7] Regeneron Pharmaceut Inc, Tarrytown, NY 10591 USA
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2006年 / 65卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：693 / 693
页数：1
相关论文
共 50 条
  • [1] Preliminary evidence for bioactivity of IL-1 trap (Rilonacept), a long acting IL-1 inhibitor, in systemic juvenile idiopathic arthritis (SJIA).
    Lovell, Daniel J.
    Giannini, Edward H.
    Kimura, Yukiko
    Li, Suzanne
    Hashkes, Philip J.
    Reiff, Andreas O.
    Wallace, Carol A.
    Onel, Karen B.
    Nadler, Douglas R.
    Rosenberg, Jeffrey R.
    Osgood, K. Gregory
    Papadopoulos, Joanne H.
    Radin, Allen R.
    ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : S325 - S326
  • [2] Placebo-controlled pilot study of rilonacept (IL-1 trap), a long acting IL-1 inhibitor, in refractory chronic active gouty arthritis
    Terkeltaub, Robert
    Schumacher, H. Ralph, Jr.
    Sundy, John
    Murphy, Frederick
    Bookbinder, Stephen
    Biedermann, Stephanie
    Mellis, Scott
    Yang, Ke
    Radin, Allen
    ARTHRITIS AND RHEUMATISM, 2007, 56 (12): : 4231 - 4232
  • [3] Placebo-controlled pilot study of rilonacept (IL-1 Trap), a long acting IL-1 inhibitor, in refractory chronic active gouty arthritis
    Radin, A.
    Terkeltaub, R.
    Schumacher, Jr H.
    Sundy, J.
    Murphy, F.
    Bookbinder, S.
    Biedermann, S.
    Yang, K.
    Mellis, S.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2008, 26 (02) : 181 - 181
  • [4] IL-1 Inhibition in Systemic Juvenile Idiopathic Arthritis
    Giancane, Gabriella
    Minoia, Francesca
    Davi, Sergio
    Bracciolini, Giulia
    Consolaro, Alessandro
    Ravelli, Angelo
    FRONTIERS IN PHARMACOLOGY, 2016, 7
  • [5] Role of interleukin-1 (IL-1) in the pathogenesis of systemic onset juvenile idiopathic arthritis and clinical response to IL-1 blockade
    Pascual, V
    Allantaz, F
    Arce, E
    Punaro, M
    Banchereau, J
    JOURNAL OF EXPERIMENTAL MEDICINE, 2005, 201 (09) : 1479 - 1486
  • [6] Treatment of 4 patients with cryopyrin-associated periodic syndromes with the long acting IL-1 inhibitor IL-1 trap
    Canna, S
    Gelabert, A
    Aksentijevich, I
    Mellis, S
    Radin, A
    Papadopoulos, J
    Barham, B
    Wilson, M
    Hawkins, P
    Kastner, D
    Goldbach-Mansky, R
    ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 : 106 - +
  • [7] Systemic onset juvenile idiopathic arthritis is an IL-1 mediated disease.
    Allantaz, F
    Arce, E
    Punaro, M
    Banchereau, J
    Pascual, V
    CLINICAL IMMUNOLOGY, 2005, 115 : S44 - S45
  • [8] The IL-1 trap rilonacept resolves and prevents recurrent pericarditis
    Irene Fernández-Ruiz
    Nature Reviews Cardiology, 2021, 18 : 73 - 73
  • [9] The IL-1 trap rilonacept resolves and prevents recurrent pericarditis
    Fernandez-Ruiz, Irene
    NATURE REVIEWS CARDIOLOGY, 2021, 18 (02) : 73 - 73
  • [10] Treatment of 4 patients with cryopyrin-associated periodic syndromes with the long-acting Il-1 inhibitor Il-1 trap.
    Canna, S
    Gelabert, A
    Aksentijevich, I
    Radin, A
    Papadopoulos, J
    Barham, B
    Wilson, M
    Hawkins, P
    Kastner, D
    Goldbach-Mansky, R
    ARTHRITIS AND RHEUMATISM, 2005, 52 (09): : S274 - S274
12345